Skip to content
144.57 USD 0.29% +0.42
OPEN 144.11
DAY RANGE 145.08 - 142.68
52 WEEK RANGE 168.11 - 130.96
Interactive Brokers Logotype

Buy ABBV stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 254.5B
Enterprise value 302.4B
Trailing pe 39.171192
Forward pe 12.928251
Peg ratio 12.928251
Price to sales ttm 4.615738
Price to book mrq 21.043795
Enterprise to revenue 5.485
Enterprise to ebitda 10.804


Fiscal year ends 2022-12-31
Most recent quarter 2023-09-30
Profit margin 0.118140005
Operating margin 0.17757
Return on assets ttm 0.086540006
Return on equity ttm 0.46321
Income statement
Revenue ttm 55.1B
Revenue per share ttm 31.173
Quarterly revenue growth -0.06
Gross profit ttm 41.5B
Ebitda 16.7B
Net income to common ttm 6.5B
Diluted eps ttm 3.68
Quarterly earnings growth yoy -0.55
Balance sheet
Total cash mrq 13.3B
Total cash per share mrq 7.527
Total debt mrq 61.2B
Total debt to equity mrq 504.427
Current ratio mrq 0.955
Book value per share mrq 6.85
Cash flow
Operating cash flow ttm 25.5B
Levered free cash flow ttm 24.1B

Stock statistics

Shares outstanding 1.8B
Float shares 1.8B
Avg 10 volume 4.8M
Avg 30 volume 5.6M
Shares short 11.1M
Short ratio 1.9
Short percent of shares outstanding 0.0063
Percent held by insiders 0.00131
Percent held by institutions 0.71415

Stock price summary

Fifty two week low 130.96
Fifty two week high 168.11
Fifty two week change -13.246
Beta 0.449
Day 50 ma 144.3008
Day 200 ma 147.0854

Dividends and splits

Forward annual dividend rate 6.2
Forward annual dividend yield 0.0432
Trailing annual dividend rate 5.92
Trailing annual dividend yield 0.041280244
5 year average dividend yield 4.5
Payout ratio 1.6027
Dividend date 2024-02-15
Ex dividend date 2024-01-12

AbbVie (ABBV) company profile

AbbVie Inc. (NYSE: ABBV) is a research company that develops pharmaceutical products. The company offers its products in various therapeutic categories, including immunology, chronic kidney disease, hepatitis C, women’s health, oncology, and neuroscience. AbbVie also provides treatments for specific conditions, including multiple sclerosis, Parkinson’s, and Alzheimer’s.